Corinne Le Goff has been appointed president, CEO and director at Celsion, the clinical-stage biotech announced. Michael Tardugno, the company’s former president and CEO, will continue to serve as executive chairman of Celsion’s board.
Le Goff brings decades of healthcare leadership experience to Celsion as it works to advance an advanced-stage ovarian cancer treatment and a proprietary vaccine platform.
Until January, Le Goff had served as the chief commercial officer at Moderna, responsible for developing a global presence and ensuring global distribution and commercial strategy for its COVID-19 vaccine. She was succeeded in the role by Arpa Garay, formerly Merck’s chief marketing officer for human health, who was hired in April.
Prior to joining Moderna, Le Goff spent nearly six years at Amgen, rising to the role of president of its U.S. business. She also held a number of senior international roles at Roche, including country president of Roche France, as well as various leadership roles at Sanofi and Pfizer in the U.S.